Annual Total Long Term Liabilities
$166.59 M
-$310.65 M-65.09%
December 31, 2022
Summary
- As of February 21, 2025, SRNE annual total long term liabilities is $166.59 million, with the most recent change of -$310.65 million (-65.09%) on December 31, 2022.
- During the last 3 years, SRNE annual total long term liabilities has fallen by -$243.08 million (-59.34%).
- SRNE annual total long term liabilities is now -65.09% below its all-time high of $477.24 million, reached on December 31, 2021.
Performance
SRNE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$389.70 M
-$32.15 M-7.62%
June 30, 2023
Summary
- As of February 21, 2025, SRNE quarterly total long term liabilities is $389.70 million, with the most recent change of -$32.15 million (-7.62%) on June 30, 2023.
- Over the past year, SRNE quarterly long term liabilities has dropped by -$32.15 million (-7.62%).
- SRNE quarterly long term liabilities is now -18.34% below its all-time high of $477.24 million, reached on December 31, 2021.
Performance
SRNE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SRNE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.1% | -7.6% |
| 3 y3 years | -59.3% | -7.6% |
| 5 y5 years | +14.1% | -7.6% |
SRNE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.1% | at low | -18.3% | +133.9% |
| 5 y | 5-year | -65.1% | at low | -18.3% | +133.9% |
| alltime | all time | -65.1% | -100.0% | -18.3% | -100.0% |
Sorrento Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $389.70 M(-7.6%) |
| Mar 2023 | - | $421.85 M(+153.2%) |
| Dec 2022 | $166.59 M(-65.1%) | $166.59 M(-41.2%) |
| Sep 2022 | - | $283.43 M(-19.3%) |
| Jun 2022 | - | $351.05 M(-17.4%) |
| Mar 2022 | - | $425.21 M(-10.9%) |
| Dec 2021 | $477.24 M(+59.8%) | $477.24 M(+6.9%) |
| Sep 2021 | - | $446.28 M(+8.1%) |
| Jun 2021 | - | $412.94 M(+44.0%) |
| Mar 2021 | - | $286.68 M(-4.0%) |
| Dec 2020 | $298.61 M(-27.1%) | $298.61 M(-18.1%) |
| Sep 2020 | - | $364.68 M(+0.9%) |
| Jun 2020 | - | $361.51 M(-8.5%) |
| Mar 2020 | - | $395.18 M(-3.5%) |
| Dec 2019 | $409.67 M(+15.4%) | $409.67 M(-7.2%) |
| Sep 2019 | - | $441.49 M(+5.0%) |
| Jun 2019 | - | $420.44 M(+0.8%) |
| Mar 2019 | - | $417.28 M(+17.6%) |
| Dec 2018 | $354.97 M(+143.0%) | $354.97 M(+25.9%) |
| Sep 2018 | - | $281.99 M(+83.5%) |
| Jun 2018 | - | $153.66 M(+6.4%) |
| Mar 2018 | - | $144.48 M(-1.1%) |
| Dec 2017 | $146.05 M(-38.9%) | $146.05 M(-44.5%) |
| Sep 2017 | - | $263.12 M(+25.7%) |
| Jun 2017 | - | $209.29 M(-0.9%) |
| Mar 2017 | - | $211.29 M(-11.6%) |
| Dec 2016 | $239.00 M | $239.00 M(+40.2%) |
| Sep 2016 | - | $170.52 M(+9.9%) |
| Jun 2016 | - | $155.15 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $156.39 M(-8.9%) |
| Dec 2015 | $171.71 M(+637.9%) | $171.71 M(+12.6%) |
| Sep 2015 | - | $152.44 M(+388.6%) |
| Jun 2015 | - | $31.20 M(+42.8%) |
| Mar 2015 | - | $21.85 M(-6.1%) |
| Dec 2014 | $23.27 M(+14.7%) | $23.27 M(-4.8%) |
| Sep 2014 | - | $24.43 M(-3.7%) |
| Jun 2014 | - | $25.39 M(-3.2%) |
| Mar 2014 | - | $26.21 M(+29.2%) |
| Dec 2013 | $20.29 M(>+9900.0%) | $20.29 M(+324.1%) |
| Sep 2013 | - | $4.79 M(+793.9%) |
| Jun 2013 | - | $535.30 K(-12.0%) |
| Mar 2013 | - | $608.30 K(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00 |
FAQ
- What is Sorrento Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual total long term liabilities year-on-year change?
- What is Sorrento Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly long term liabilities year-on-year change?
What is Sorrento Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SRNE is $166.59 M
What is the all time high annual total long term liabilities for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual total long term liabilities is $477.24 M
What is Sorrento Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SRNE annual total long term liabilities has changed by -$310.65 M (-65.09%)
What is Sorrento Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SRNE is $389.70 M
What is the all time high quarterly long term liabilities for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly total long term liabilities is $477.24 M
What is Sorrento Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SRNE quarterly total long term liabilities has changed by -$32.15 M (-7.62%)